It was shown previously by Seki et al. that cytotoxic T lymphocytes did not use TRAIL or perforin to kill Renca tumor cells, but instead relied primarily upon FasL in vivo[34], particularly when the cognate antigen levels were low (determined with HA-expressing Renca-HA cells [46]). The gene discussed is PRF1; the disease is neoplasm.